In addition, LSD1 inhibition can enhance the sensitivity of AML cells to all-trans retinoic acid (ATRA) treatment, which was first used to treat AML by inducing cell differentiation (Lokken and Zeleznik-Le, 2012; Schenk et al., 2012). This evidence concerns the gene KDM1A and acute myeloid leukemia.